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Transient Thyrotoxicosis After Parathyroidectomy in a
Hemodialysis Patient with Secondary Hyperparathyroidism
Chieko Hamada, Yuichi Tanaka, Tomoko Sakamoto, Kayo Kaneko, Ichiyu Shou,
Mitsumine Fukui, Masaki Fukazawa,1 Yasuhiko Tomino
A 51-year-old Japanese male had been maintaining hemodialysis for 20 years. He had advanced secondary
hyperparathyroidism. He had total parathyroidectomy (PTX) and autotransplantation in 2003. After the operation,
clinical and endocrinologic findings showed transient thyrotoxicosis. There was no immunologic finding
compatible with Graves’ disease and chronic thyroiditis. After PTX, radioisotope accumulation markedly
decreased on 99mTcO
4
– thyroid gland scintigram and blood flow diminished on thyroid gland ultrasonogram.
These findings absolutely recovered with the resolution of thyrotoxicosis within 1 month. It appears that
disturbance of the microcirculation in the thyroid gland by manipulation during operation might be a cause of
transient thyrotoxicosis after PTX. It is important to consider transient thyrotoxicosis as a complication of
PTX in secondary hyperparathyroidism. [Hong Kong J Nephrol 2007;9(1):45–9]
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INTRODUCTION
Advanced secondary hyperparathyroidism (2HPT) is a
major complication in patients on dialysis. Management
of hyperphosphatemia and hypocalcemia using
phosphorous binders and vitamin D preparation is first-
line therapy in 2HPT. Patients whose serum phosphorus
(Pi) and calcium (Ca) levels are within guideline limits
receive vitamin D pulse therapy [1]. As the therapy often
presents elevation in serum Pi and Ca levels, it is
impossible to maintain parathyroid hormone (PTH)
concentration between 150 and 300 pg/mL. Around 2%
of dialysis patients in Japan receive parathyroidectomy
(PTX) and/or percutaneous ethanol injection of
parathyroid (PEIT) [2]. In 1960, PTX was performed
in hemodialysis patients with 2HPT [3]. Total PTX with
partial subcutaneous transplantation is widely used in
patients with 2HPT since many patients with subtotal
PTX have recurrent hyperparathyroidism [4–8].
However, it is difficult to identify residual and/or
slightly enlarged parathyroid glands before and during
PTX. Here, we report a hemodialysis patient with the
complication of transient thyrotoxicosis due to
intraoperative thyroid gland manipulation after PTX.
CASE REPORT
A 51-year-old Japanese man was admitted to Juntendo
University Hospital because of lumbago, irritation and
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skin pruritus. He was placed on hemodialysis in 1984
in another hospital due to chronic glomerulonephritis
and was diagnosed with 2HPT several years ago. Severe
hypercalcemia and hyperphophatemia attributed to
resistance to vitamin D
3
 treatment had been observed
for 2 years. He was transferred to our hospital to
evaluate the degree of 2HPT and to determine if PTX
was indicated. Laboratory data on admission are shown
in Table 1. The levels of intact PTH, Ca and Pi in sera
significantly increased although bone alkaline
phosphatase (ALP) activity was in the normal range.
Three enlarged parathyroid glands were detected by
ultrasonography. He had no special family history and
no previous autoimmune disease, including thyroid
disease.
Three enlarged parathyroid glands (one on the right,
two  on  the  l e f t )  were  de tec t ed  by  99mTc-
methoxyisobutylisonitrile (MIBI) scintigraphy. No
ectopic parathyroid gland was observed on scintigraphy.
The three identified hyperplastic parathyroid glands
were removed easily by surgery, but the remaining right
upper parathyroid gland was not detected during the
neck exploration. The histologic diagnosis of all excised
parathyroid glands was hyperplasia. A section of a
parathyroid gland was implanted in the right forearm.
The level of intact PTH rapidly decreased from 90.1
pmol/L to 0.7 pmol/L 7 days after the operation. Three
days after PTX, the patient had a high fever (38°C)
with tachycardia (heart rate, 199 beats/min from around
65 beats/min). Flomoxef sodium (FMOX) 0.5 g had
been administered daily for 3 days postoperatively in
order to prevent infection, but after the appearance of
the high fever, the antibiotic was changed to imipenem/
cilastatin sodium (IPM/CS) 0.5 g/day.
No impairment of physiologic status or evidence of
infection was observed. According to thyroid function
tests, thyrotoxicosis was confirmed (Table 2). On day
10, the serum levels of free triiodothyronine (FT3), free
tyroxine (FT4) and thyroglobulin were elevated. The
serum level of thyroid-stimulating hormone (TSH) was
markedly decreased. Within 14 days after PTX, the
clinical findings attributed to thyrotoxicosis such as
fever, sweating and tachycardia subsided without any
treatment. The cause of thyrotoxicosis might not be
immunologic disorders since antithyroid peroxidase,
anti-thyroglobulin and anti-TSH receptor antibodies
were not detected. The findings of 99mTcO
4
– thyroid
gland scintigraphy are shown in Figure 1. The level of
radioisotope (RI) uptake after 20 minutes on day 18
after PTX was 0.45%, which is equal to the background
levels. The values recovered to the normal range 7
months later. The blood flow in thyroid tissues was
shown to be decreased on ultrasonography 17 days after
the operation (Figure 2). Blood flow returned to normal
4 months after thyroid function tests showed normal
results.
A significant increase in serum FT3 and FT4 was
associated with a marked reduction in serum TSH after
PTX (Figure 3). The levels of FT3 and FT4 in sera
returned to the normal range within 1 month after the
operation. The level of serum TSH was increased at 1
month after PTX and returned to the normal range 3
months later. Antithyroid peroxidase, anti-thyroglobulin
and anti-TSH receptor antibodies in sera did not elevate
for 12 months after improvement of thyroid function
(data not shown).
Table 1. Laboratory data on admission
Parameter Value on admission Normal range
WBC 4,400/mL 3,900–9,700/mL
RBC 330 × 104/mL 430 × 104 – 56 × 104/mL
Hemoglobin 10.9 mg/dL 13.4–17.1 mg/dL
Hematocrit 32.6% 40.4–51.1%
Platelet count 22 × 104/mL 15.3–34.6 × 104/mL
Total protein 10.9 μg/L 65–85 μg/L
Albumin 594.5 μmol/L 580–7,540 μmol/L
Urea nitrogen 15 mmol/L 3.2–7.5 mmol/L
Creatinine 1,071.4 mmol/L 53.0–88.4 mmol/L
Uric acid 374.9 mmol/L 208.3–410.6 mmol/L
Sodium 141 mmol/L 58.7–63.1 mmol/L
Potassium 4.9 mmol/L 0.89–1.28 mmol/L
Chloride 104 mmol/L 27.1–30.2 mmol/L
Calcium 2.78 mmol/L 2.20–2.64 mmol/L
Phosphorus 2.03 mmol/L 0.65–1.45 mmol/L
Intact PTH 90.1 pmol/L
Osteocalcin 92 μg/L 3.1–12.7 μg/L
ALP 208 IU/L 110–348 IU/L
Bone ALP 81 IU/L < 35.5 IU/L
WBC = white blood cell count; RBC = red blood cell count;
PTH = parathyroid hormone; ALP = alkaline phosphatase.






TSH < 0.01 0.56–4.4 mU/L
Free triiodothyronine 7.6 3.4–7.2 pmol/L
Free thyroxine 31 9–22 pmol/L
Thyroglobulin 180 ≤ 30 μg/L
Anti-TPO antibodies ≤ 300 ≤ 300 U/L
Anti-thyroglobulin antibodies ≤ 300 ≤ 300 U/L
Anti-TSH receptor antibodies 7.1 ≤ 15%
TSH = thyroid stimulating hormone; TPO = thyroid peroxidase.
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Figure 1. Findings of 99mTcO4
– thyroid gland scintigram. (A) The level of RI uptake 20 minutes after injection was 0.45%, equivalent to
the background level on day 18 after parathyroidectomy (PTX). (B) Seven months post-PTX, the level of RI uptake 20 minutes after
injection was 2.46%, i.e. it had recovered to the normal range.
Figure 2. Ultrasonography of the thyroid gland shows: (A) decreased blood flow in thyroid tissues 17 days after parathyroidectomy
(PTX); (B) normal blood flow 7 months after PTX, when thyroid function had also recovered to within normal levels.
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DISCUSSION
In this report, we have described a hemodialysis patient
with advanced 2HPT, with no thyroid function disorder,
who had the complication of transient thyrotoxicosis
after total PTX. Many dialysis patients have advanced
2HPT in Japan. It is generally recognized that there are
various degrees of parathyroid hyperplasia in patients
with advanced 2HPT. Vitamin D
3
 pulse therapy or
vitamin D
3
 injection is the first line of treatment in
hemodialysis patients with advanced 2HPT [9]. PTX
is a well-known treatment for advanced 2HPT in
patients with chronic renal failure; 10–30% of
hemodialysis patients who have been on hemodialysis
for more than 10 years undergo PTX [10]. In advanced
2HPT, multiple enlarged parathyroid glands are present.
Post-PTX, some patients continue to have high PTH or
experience an increase in intact PTH again, and
enlarged residual parathyroid glands have been found
in patients with subtotal PTX [4,6,7]. Total PTX and
subcutaneous autotransplantation has recently been
performed in patients with 2HPT. Since 15–20% of
parathyroid glands are present in an ectopic region,
about 15% of patients have more than five parathyroid
glands [11]. Therefore, it is difficult to identify all the
parathyroid glands, including normal parathyroid
glands, before and during the operation.
Complications of PTX include injury of recurrent
nerves or thyroid arteries, remaining parathyroid glands
and hematoma. The most common complication is
nerve injury. To remove all parathyroid glands
completely, including non-enlarged or ectopic
parathyroid glands, looking for the parathyroid glands
in extensive cervical region and intraoperative
histologic examinations need to be performed. During
operation, recurrent nerves and thyroid arteries are
marked by ribbons and stretched to place out operation
area; these manipulations might induce ischemia,
bleeding and adhesion with thyroid destruction. In the
present case, three enlarged parathyroid glands were
detected before the operation. Since parathyroid glands
resemble lymph nodes or fatty tissues, the residual non-
hyperplastic parathyroid gland was examined
pathologically behind the thyroid gland during the
operation.
This patient showed non-infection high fever with
tachycardia due to thyrotoxicosis several days after
PTX, but these signs improved without any treatment.
Since the patient had no thyroid dysfunction before
preoperatively, and thyrotoxicosis recovered
completely within 1 month prior to recovery of blood
flow, the clinical findings were consistent with acute
thyroiditis. It appears that palpation of the thyroid gland
during neck exploration might produce the clinical and
biochemical features of transient thyrotoxicosis.
Walfish et al reported that patients with thyrotoxicosis
after surgery did not have thyroidal pain and fever [12].
Transient thyroiditis occurred within 2 weeks after
operation and recovered completely without treatment
within a few months [13]. Lindbolm et al reported that
11 of 26 patients with primary hyperparathyroidism
(1HPT) had increase of T4 and T3 concentration, along
with elevated TSH level following PTX. They
concluded that surgical manipulation of the thyroid
gland is not solely responsible, but that a TSH-mediated
mechanism may be a contributing factor [14]. Dudczak
et at reported TRH-mediated release of TSH in response
to decrease in serum Ca concentration, when sodium
EDTA was administrated, which was recognized in
healthy subjects [15]. As the level of serum TSH was
completely suppressed at the peak of thyrotoxicosis,
TRH-mediated TSH release is not applicable in this
case.
The reason for the postoperative hyperthyroidism
in this case is likely to be thyroid manipulation during
parathyroid surgery, because thyroid ultrasonography
and isotope thyroid scan were consistent with diffuse
thyro id i t i s  w i th  r emarked  suppress ion  o f
microcirculation. Stang et al examined the risk factors
of postoperative hyperthyroidism in 199 consecutive
patients who had parathyroid exploration for sporadic
1HPT. They manifested hyperthyroidism independent
of age, severity of hyperparathyroidism, anatomic or
pathologic features, operation time, and magnification
of preoperative Ca concentration, but it was associated
with use of lithium and bilateral exploration. They also
reported that 15% of patients had symptoms. Of those,
five patients (4%) were found to have thyrotoxicosis
[1]. It is generally considered that 20% of patients with
subtotal PTX have recurrent 2HPT [16,17]. Therefore,
total PTX with or without autotransplantation in the
forearm is recommended in patients with 2HPT. Lim
et al reported that acute thyroiditis as a result of surgical
manipulation or trauma following PTX for 2HPT
occurred in a peritoneal dialysis patient [18]. He pointed
out that the clinical picture resembled sepsis or acute
inflammatory thyroiditis. As bilateral exploration is
performed during total PTX in patients with 2HPT, it
is important to be alert for postoperative thyrotoxicosis
when patients have fever, tachycardia and watery
diarrhea, which resemble sepsis. It is necessary to
evaluate thyroid function before and after PTX in order
to diagnose traumatic transient thyroiditis earlier and
to avoid unnecessary treatment.
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